Indian pharmaceutical market sustains double-digit growth driven by pricing and new therapies in July 2026

India’s pharma sector continued its robust performance in July 2026, with a 12.1% rise in value driven by premium therapies, new launches, and pricing strategies, despite subdued unit growth, according to PharmaTrac’s latest review. India’s pharmaceutical market continued its strong…













